Drug Price Transparency

Beginning in May of last year, the Trump administration began searching for ways to curb out-of-control prescription drug costs—referring to the initiative as American Patients First. This effort is finally seeing some traction, with the administration publishing its first final rule on the matter.

Drug companies will now be “… required to disclose to patients the list price for prescription drugs in TV ads,” according to the Department of Health and Human Services (HHS).

This rule won’t take effect until 60 days after its publication, so employers should expect to see action starting in July.

Refer to the attached new brief for detail and contact your NEEBCo representative with questions.

News Brief – HHS Drug Transparency